Back to search
Treatment of Venous Thromboembolism in Cancer Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment of Venous Thromboembolism in Cancer Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Treatment of Venous Thromboembolism in Cancer Patients trials you may qualify forThe purpose of this observational study is to explore the incidence, risk factors, and relationship with therapeutic outcomes of VTE (venous thromboembolism) an…
Patients with genitourinary cancers (ex: bladder, testicular, kidney) are at high risk of developing blood clots if they receive systemic therapy (ex: chemother…
The objective of this study is to prospectively develop a risk assessment model (RAM) that accurately identifies anticoagulated cancer-associated thrombosis (CA…
The study is classified as an observational pharmacological study, spontaneous, monocentric, and both retrospective and prospective for adult patients with a di…
GynCAT is a prospective cohort study that will be conducted on female patients with gynecologic malignancies scheduled for systemic antineoplastic treatment, ai…
This is a Phase 3, multicenter, open-label, blinded endpoint study to evaluate the effect of abelacimab relative to dalteparin on venous thromboembolism (VTE) r…
This is a Phase 3,multicenter, randomized, open-label, blinded endpoint evaluation study comparing the effect of abelacimab relative to apixaban on venous throm…
The purpose of this study is to help find how safe current practices are when managing blood thinners in people with cancer who are having surgery or medical pr…